P.F. Chang’s Recall Over Foreign Particle Contamination Expanded

Federal health officials have announced a recall expansion of P.F. Chang’s frozen chicken, beef and shrimp meals, after receiving notice from a supplier that small metal fragments may have entered the ingredients used to make the sauce for the meals. 

The P.F. Chang’s frozen chicken, beef, and shrimp product meals recall expansion was announced on July 16, after the manufacturer recognized additional products that may have been contaminated with sharp metal fragments that could pose choking and laceration hazard to consumers.

The products included in the recall expansion may contain similar metal fragments that may have entered the products originally recalled.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

An initial recall of P.F. Chang’s frozen food was announced on July 7, by the FDA after the manufacturer ConAgra Foods was notified by its sugar supplier that an employee saw metal fragments in the sugar used in the making of the recalled meals sauce.

An investigation determined that small metal fragments measuring between 2 mm and 9mm in length may have entered the sugar product during production at the supplier’s warehouse. The source of the contamination has not been determined to date.

Customers are being advised to stop consuming the products immediately as consumption of the products containing the flexible metal fragments could cause temporary reflexive choking, possible lacerations, and irritation of the gastrointestinal system. To date no injuries have been reported.

According to ConAgra’s recall notice, only the recalled meals sold at grocery stores and other various retailers are impacted. Food products served in P.F. Chang’s restaurants are not impacted by the recall.

The July 7 recall included roughly 195,000 pounds of 22 ounce bagged meal packages of P.F. Chang’s Home Menu meals sold in various flavors. The recalled flavors include Signature Spicy Chicken, Mongolian Style Beef, Beef with Broccoli, Sweet & Sour Chicken, General Chang’s Chicken, Garlic Chicken with Dan Dan Noodles, and Grilled Teriyaki with Lo Mein Noodles. The products have varying “Best By” and case code numbers but can be identified by locating the recalled establishment number “EST.233” or “EST.P-115” inside the USDA mark of inspection.

The expansion recently released by the FDA now includes additional UPC codes and lots of the previously recalled flavors of beef, chicken meals and has addedthe Home Menu Brand Shrimp Lo Mein meals sold in 22 ounce packages to the recall. All of the recalled products contain a “Best By” date ranging from May 26, 2017 through June 17, 2017.

The recall has been given Class I status by the United Stated Department of Agriculture (USDA), indicating there is a reasonable probability that the consumption of the products will cause serious, adverse health consequences or death.

Consumers are being asked to stop consuming the recalled products immediately and either discard of any remaining inventory or return them to the place of purchase for a full refund. Customers with further questions may contact ConAgra at 1-800-252-0634.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

EU Launches Investigation Into Ozempic Vision Loss Problems
EU Launches Investigation Into Ozempic Vision Loss Problems (Posted 3 days ago)

Following nearly 20 reports of vision problems from Ozempic or Wegovy since a study was published in July 2024, Danish health officials are calling for an EU investigation into the safety of semaglutide-based drugs.